MFAP4 and lung adenocarcinoma: Further studies revealed that upregulation of FOXF1/MFAP4 promoted anti-tumor immune responses through augmented dendritic cell and CD4+ T cell infiltration, facilitating crosstalk between lung adenocarcinoma and immune cells, and induction of multiple anti-tumor immune pathways [38].